GFM
PYXS icon

GF Fund Management’s Pyxis Oncology PYXS Stock Holding History

GF Fund Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92K Buy
1,316
+39
+3% +$59 ﹤0.01% 621
2025
Q4 		$1.47K Sell
1,277
-57
-4% -$201 ﹤0.01% 642
2025
Q3 		$2.96K Sell
1,334
-95
-7% -$137 ﹤0.01% 620
2025
Q2 		$1.57K Hold
1,429
– – ﹤0.01% 652
2025
Q1 		$1.4K Buy
1,429
+180
+14% +$240 ﹤0.01% 657
2024
Q4 		$1.95K Buy
+1,249
New +$3.6K ﹤0.01% 636

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GF Fund Management's PYXS Position: Q1 2026 in Review

GF Fund Management increased its Pyxis Oncology (PYXS) stake by 3.1% in Q1 2026, buying an estimated $59 and bringing the position to 1,316 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #621.

GF Fund Management first reported a position in PYXS in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.96K in Q3 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • GF Fund Management held 1,316 shares of Pyxis Oncology worth $1.92K as of Q1 2026.
  • GF Fund Management bought 39 Pyxis Oncology shares in Q1 2026, an estimated $59.
  • Pyxis Oncology made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #621 holding.
  • GF Fund Management first reported a position in Pyxis Oncology in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Pyxis Oncology position peaked at $2.96K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.